Telehealth Co. Expands With Six New Contracts in Three States
Source: Streetwise Reports  (6/13/23)
New contracts are expected to add more than 3,000 new patients to Reliq Health Technologies Inc.'s platform by the first quarter of next year, the company said. More >

Healthcare Tech Firm Grows Revenue 10% YOY in Q1/23
Source: Rob Goff  (6/5/23)
This positive start to 2023 bodes well for the company turning EBITDA positive later this year, which is expected, noted an Echelon Capital Markets report. More >

Telehealth Co. Notches First Profitable Quarter
Source: Streetwise Reports  (6/2/23)
Reliq Health Technologies announces record revenues for the three months ending March 31 and its first profitable quarter after a loss during the same quarter in 2022. More >

Telehealth Co. Signs Contract With US Health Plan Serving 1 Million Patients
Source: Streetwise Reports  (5/18/23)
Telehealth company Reliq Health Technologies signs a contract with a U.S. health plan that operates in five states with over 3,000 doctors and more than 1 million patients. More >

Telehealth Co. Expands into Arkansas
Source: Streetwise Reports  (5/5/23)
Telehealth company Reliq Health Technologies signs five new contracts in four states for its iUGO platform, including its first contract in the state of Arkansas, where chronic diseases cost billions annually. More >

CEO: Telehealth Co. in 'More Comfortable Cash Position'
Source: Streetwise Reports  (4/14/23)
Telehealth company Reliq Health Technologies Inc. expects to be profitable for the quarter ending in June and initiate a share buyback program this year, its CEO told shareholders this week. More >

Telehealth Co. Signs Largest Client Yet
Source: Streetwise Reports  (3/30/23)
Onboarding will begin in April for the healthcare system that has more than 1,200 care centers in seven states. More >

Telemedicine Co. Sees Record Revenues on Software, Services Sales
Source: Streetwise Reports  (3/13/23)
Reliq Health Technologies Inc. reports that software and services revenue continues to increase, leading to record cash intake for the quarter that ended Dec. 31, 2022. More >

AI-Infused Telehealth Platform Absorbs New Patients
Source: Streetwise Reports  (2/22/23)
Telemedicine company Reliq Health Technologies Inc., which uses artificial intelligence in its software's algorithms, has gained six new contracts and more than 3,000 new patients. More >

Addiction Therapy Company Secures Major UK Endorsement
Source: Streetwise Reports  (2/7/23)
Pharmaceutical powerhouse Awakn has been awarded Innovative Licensing and Access Pathway (ILAP) access to UK markets. This classification, equivalent to FDA Breakthrough Therapy designation in the U.S., allows the company to expedite development growth in the region. More >

Exploring Why The Economist Named this Biotech 'One To watch' in 2023
Source: Streetwise Reports  (1/23/23)
As more researchers delve into the medicinal potentials of once-verboten compounds, forward-thinking companies like Awakn Life Sciences Corp. are leading the charge to map their most useful aspects and open access for people who need help now. Read more to learn what catalysts Awakn has in store and why The Economist touched on this treatment as one of their top stories of 2023. More >

Telehealth Co. Expects More Growth in 2023
Source: Streetwise Reports  (1/20/23)
Officials at telemedicine company Reliq Health Technologies say they expect to accelerate growth "significantly" in 2023, which could lead to a share buyback program. More >

Organ Transplant Co.'s Q3 Revenues Rise 378%
Source: Streetwise Reports  (11/4/22)
Shares of medical technology firm TransMedics Group Inc. traded 24% higher to a new 52-week high after the company reported Q3/22 financial results highlighting a 378% YoY increase in net revenue and raised its FY/22 revenue estimates to US$80-85 million. More >

Telemedicine Co. Surges on Revenue News
Source: Streetwise Reports  (11/4/22)
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar. More >

CRO Firm's Shares Rise on Q3 Earnings and Growth Prospects
Source: Streetwise Reports  (10/26/22)
Shares of full-service clinical contract research organization Medpace Holdings Inc. traded 37% higher yesterday after the company reported Q3/22 financial results that included a nearly 30% YoY increase in revenue. More >

US Biotech Firm Keeps Growing Revenue
Source: Scott Henry  (9/26/22)
Revenue last quarter was strong, and management expects to increase revenue 20% this fiscal year, noted a ROTH Capital Partners report. More >

Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World
Source: Streetwise Reports  (9/21/22)
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc. More >

Co. Pursuing Ketamine for Addiction Forms Partnership
Source: Andrew Partheniou  (8/16/22)
In landing this first licensing deal, the life sciences firm "shows good progress towards a potentially high-margin business," noted a Stifel report. More >

Expert Believes Health Co. Blooms With Opportunity
Source: Clive Maund  (8/2/22)
Expert Clive Maund touches on the latest news with Bloom Health Partners Inc. from the enthusiastic buying toward the end of June to whether he believes the health company is still bullish. More >

Amazon Makes $3.9B Bid for Virtual Primary Care Co.
Source: Streetwise Reports  (7/21/22)
Shares of One Medical traded nearly 70% higher after the company reported it agreed to be acquired by Amazon Inc. for $18.00 per share in an all-cash deal valued at $3.9 billion. More >

Biotech Co.'s Phase 3 Trial First to Get Grant
Source: Streetwise Reports  (7/20/22)
A revenue-generating junior biotech company based in the U.K. has become the first public company to be approved for a government grant to fund most of a Phase 3 study exploring the use of psychedelics to treat alcohol use disorder. It could be a catalyst for the share price. More >

Healthcare Co.’s Psychedelic-Assisted Treatments Have ‘Blockbuster Drug Potential’
Source: Patrick Trucchio  (7/15/22)
Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with alcohol use disorder (AUD) or alcoholism. One company hopes to bring its treatments to clinics throughout Europe and become the go-to standard of care for AUD. More >

Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry
Source: Jason McCarthy  (7/14/22)
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report. More >

Analyst Sees 'Attractive Long-Term Economics' for Healthcare Co.
Source: Andrew Partheniou  (7/13/22)
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments. More >

MedTech Co.'s Shares Maneuver Higher on Q1 Revenue Growth
Source: Streetwise Reports  (7/1/22)
Shares of personalized, member-focused healthcare solutions company Accolade Inc. traded 29% higher after the company reported financial results for Q1/23 highlighting a 44% YoY increase in revenue and significant improvements in adjusted gross margin. More >